Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIGID: Biomarkers for Glucocorticoid-Induced Bone Loss
NCT06421597Phase 2Completed
- Sponsor
- University Hospital Odense
- Start
- Nov 2024
- Primary completion
- Mar 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of prednisolone, sponsored by University Hospital Odense. Started Nov 2024; status: completed.
02
Drugs
prednisolone
Beyond the preview
Go deeper on NCT06421597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06421597.